Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial

Morano Amado, Luis

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/2283

ISSN: 0815-9319

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2013

Journal title

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Type of content

Publicación de congreso